Amphastar Pharmaceuticals (AMPH) Short Interest Ratio & Short Volume $21.27 +0.09 (+0.42%) Closing price 04:00 PM EasternExtended Trading$21.64 +0.37 (+1.72%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Amphastar Pharmaceuticals Short Interest DataAmphastar Pharmaceuticals (AMPH) has a short interest of 4.06 million shares, representing 11.74% of the float (the number of shares available for trading by the public). This marks a -0.49% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 499,488 shares to cover all short positions.Current Short Interest4,060,000 sharesPrevious Short Interest4,080,000 sharesChange Vs. Previous Month-0.49%Dollar Volume Sold Short$93.22 millionShort Interest Ratio7.3 Days to CoverLast Record DateJune 30, 2025Outstanding Shares47,140,000 sharesFloat Size34,580,000 sharesShort Percent of Float11.74%Today's Trading Volume675,607 sharesAverage Trading Volume499,488 sharesToday's Volume Vs. Average135% Short Selling Amphastar Pharmaceuticals? Sign up to receive the latest short interest report for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAMPH Short Interest Over TimeAMPH Days to Cover Over TimeAMPH Percentage of Float Shorted Over Time Amphastar Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20254,060,000 shares $93.22 million -0.5%11.7%7.3 $22.96 6/15/20254,080,000 shares $105.35 million -0.5%11.8%7.3 $25.82 5/31/20254,100,000 shares $106.11 million +2.2%11.8%7 $25.88 5/15/20254,010,000 shares $97.52 million +24.9%11.5%6.4 $24.32 4/30/20253,210,000 shares $78.36 million +8.1%9.2%5.1 $24.41 4/15/20252,970,000 shares $69.80 million -13.2%8.5%4.9 $23.50 3/31/20253,420,000 shares $99.15 million -11.2%9.7%5.5 $28.99 3/15/20253,850,000 shares $102.64 million -6.8%10.9%6.2 $26.66 2/28/20254,130,000 shares $117.42 million +1.5%11.6%6.9 $28.43 2/15/20254,070,000 shares $126.25 million -1.2%11.3%7.4 $31.02 Get the Latest News and Ratings for AMPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amphastar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20254,120,000 shares $143.66 million -10.4%11.5%7.5 $34.87 1/15/20254,600,000 shares $166.70 million -4.6%12.9%8.8 $36.24 12/31/20244,820,000 shares $178.97 million +10.3%13.5%10.1 $37.13 12/15/20244,370,000 shares $184.59 million +6.1%12.2%10.3 $42.24 11/30/20244,120,000 shares $186.18 million -2.8%11.5%11 $45.19 11/15/20244,240,000 shares $189.15 million -2.3%11.8%12 $44.61 10/31/20244,340,000 shares $219.30 million +2.6%12.2%12.6 $50.53 10/15/20244,230,000 shares $208.58 million -2.8%11.7%12 $49.31 9/30/20244,350,000 shares $211.11 million +5.3%12.0%11.9 $48.53 9/15/20244,130,000 shares $198.61 million -1.9%11.4%10.4 $48.09 8/31/20244,210,000 shares $205.20 million No Change12.0%11.2 $48.74 8/15/20244,210,000 shares $190.80 million -7.5%12.0%10.9 $45.32 7/31/20244,550,000 shares $198.02 million +7.6%12.9%11.6 $43.52 7/15/20244,230,000 shares $163.95 million +1.4%12.0%11.7 $38.76 6/30/20244,170,000 shares $166.80 million +0.5%11.9%11.5 $40.00 6/15/20244,150,000 shares $168.03 million +10.4%11.8%12.1 $40.49 5/31/20243,760,000 shares $159.16 million -0.3%10.3%10.3 $42.33 5/15/20243,770,000 shares $160.00 million -5.5%10.7%9.2 $42.44 4/30/20243,990,000 shares $164.59 million +3.1%11.4%9.7 $41.25 4/15/20243,870,000 shares $157.82 million +5.5%11.0%9 $40.78 3/31/20243,670,000 shares $161.15 million +1.9%10.6%7.8 $43.91 3/15/20243,600,000 shares $154.98 million -3.2%10.4%7.5 $43.05 2/29/20243,720,000 shares $173.24 million +3.6%10.3%7.5 $46.57 2/15/20243,590,000 shares $199.28 million +12.5%10.0%7.9 $55.51 1/31/20243,190,000 shares $170.22 million +8.5%8.9%6.6 $53.36 1/15/20242,940,000 shares $159.38 million +5.8%8.2%6.5 $54.21 12/31/20232,780,000 shares $171.94 million -1.8%7.8%6.5 $61.85 12/15/20232,830,000 shares $160.18 million -0.7%8.0%6.9 $56.60 11/30/20232,850,000 shares $160.51 million -1.4%8.0%6 $56.32 11/15/20232,890,000 shares $166.23 million +15.6%8.1%6.4 $57.52A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/31/20232,500,000 shares $113.18 million -6.0%6.9%5.7 $45.27 10/15/20232,660,000 shares $121.72 million +1.5%7.3%6.2 $45.76 9/30/20232,620,000 shares $120.49 million -2.6%7.2%5.8 $45.99 9/15/20232,690,000 shares $123.12 million +106.9%7.4%5.9 $45.77 8/31/20231,300,000 shares $69.30 million -12.8%3.6%3 $53.31 8/15/20231,490,000 shares $85.30 million +4.2%4.1%3.4 $57.25 7/31/20231,430,000 shares $86.79 million -30.9%4.0%3.2 $60.69 7/15/20232,070,000 shares $115.65 million +3.0%5.8%4.5 $55.87 6/30/20232,010,000 shares $115.51 million -3.4%5.6%4.5 $57.47 6/15/20232,080,000 shares $108.64 million +10.6%5.8%4.7 $52.23 5/31/20231,880,000 shares $83.42 million -1.1%5.3%4.7 $44.37 5/15/20231,900,000 shares $79.34 million +2.2%5.3%4.8 $41.76 4/30/20231,860,000 shares $66.53 million +29.2%5.3%5.3 $35.77 4/15/20231,440,000 shares $60.70 million +9.9%4.1%4.5 $42.15 3/31/20231,310,000 shares $49.13 million -10.3%3.7%4.6 $37.50 3/15/20231,460,000 shares $53.79 million -16.6%4.1%5.7 $36.84 2/28/20231,750,000 shares $55.76 million +1.2%4.7%7.4 $31.86 2/15/20231,730,000 shares $56.33 million +0.6%4.6%8.3 $32.56 1/31/20231,720,000 shares $52.05 million +1.2%4.6%8.1 $30.26 1/15/20231,700,000 shares $49.23 million -1.2%4.6%7.9 $28.96 12/30/20221,720,000 shares $48.19 million -2.3%4.6%7.9 $28.02 12/15/20221,760,000 shares $50.65 million -0.6%4.8%7.9 $28.78 11/30/20221,770,000 shares $52.20 million -3.8%4.8%7.7 $29.49 11/15/20221,840,000 shares $52.20 million -5.2%5.0%7.5 $28.37 10/31/20221,940,000 shares $59.95 million +1.6%5.2%6.9 $30.90 10/15/20221,910,000 shares $54.49 million +1.1%5.1%6.6 $28.53 9/30/20221,890,000 shares $53.11 million -9.1%5.0%6.2 $28.10 9/15/20222,080,000 shares $61.01 million -5.0%5.6%6 $29.33 8/31/20222,190,000 shares $64.82 million +1.4%5.9%5.1 $29.60 8/15/20222,160,000 shares $70.26 million -5.7%5.8%4.2 $32.53 7/31/20222,290,000 shares $85.62 million -3.0%6.1%4.1 $37.39 7/15/20222,360,000 shares $87.41 million +2.6%6.3%4.2 $37.04 6/30/20222,300,000 shares $80.02 million -11.5%6.2%3.8 $34.79 6/15/20222,600,000 shares $81.43 million +11.1%7.0%4.3 $31.32 5/31/20222,340,000 shares $86.91 million -6.8%6.3%4.3 $37.14 5/15/20222,510,000 shares $88.70 million +6.8%6.8%5.1 $35.34 4/30/20222,350,000 shares $83.35 million +15.2%6.4%5 $35.47 4/15/20222,040,000 shares $84.74 million +4.6%5.5%4.4 $41.54 3/31/20221,950,000 shares $70.01 million -3.5%5.4%4.7 $35.90 3/15/20222,020,000 shares $70.17 million +1.5%5.5%5.5 $34.74 2/28/20221,990,000 shares $55.14 million -2.9%5.5%6.3 $27.71 2/15/20222,050,000 shares $54.12 million +5.7%5.6%7.2 $26.40 1/31/20221,940,000 shares $44.79 million -1.5%5.6%7.1 $23.09 1/15/20221,970,000 shares $49.98 million -2.0%5.7%9.2 $25.37 12/31/20212,010,000 shares $46.81 million -2.9%5.8%10 $23.29 12/15/20212,070,000 shares $46.26 million -2.4%6.0%11.3 $22.35 11/30/20212,120,000 shares $41.47 million +7.1%6.1%12.5 $19.56 11/15/20211,980,000 shares $41.88 million -14.3%5.7%11.9 $21.15 10/29/20212,310,000 shares $43.15 million +1.3%6.6%16.3 $18.68 10/15/20212,280,000 shares $43.57 million No Change6.5%15.2 $19.11A grave, grave error. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 9/30/20212,280,000 shares $43.34 million -5.8%6.5%14.1 $19.01 9/15/20212,420,000 shares $43.27 million +0.8%6.9%12.5 $17.88 8/31/20212,400,000 shares $47.09 million +3.0%6.9%11 $19.62 8/13/20212,330,000 shares $45.67 million -2.5%6.7%10.5 $19.60 7/30/20212,390,000 shares $50.07 million -1.2%6.9%10.2 $20.95 7/15/20212,420,000 shares $48.45 million -0.8%7.0%11 $20.02 6/30/20212,440,000 shares $49.19 million -7.9%7.1%11.1 $20.16 6/15/20212,650,000 shares $52.95 million +1.9%7.7%14.4 $19.98 5/28/20212,600,000 shares $49.19 million No Change7.5%15.4 $18.92 5/14/20212,600,000 shares $50.86 million -1.1%7.5%13.4 $19.56 4/30/20212,630,000 shares $46.21 million +3.5%7.6%13.7 $17.57 4/15/20212,540,000 shares $44.20 million +2.8%7.3%13.5 $17.40 3/31/20212,470,000 shares $44.46 million +2.9%7.3%12.6 $18.00 3/15/20212,400,000 shares $46.46 million -6.6%7.1%11.2 $19.36 2/26/20212,570,000 shares $45.98 million +0.8%7.5%12 $17.89 2/12/20212,550,000 shares $48.81 million -1.9%7.5%13.1 $19.14 1/29/20212,600,000 shares $48.28 million +1.6%7.3%12.8 $18.57 1/15/20212,560,000 shares $49.31 million -4.1%7.1%12.6 $19.26 12/31/20202,670,000 shares $53.00 million +3.5%7.5%13.6 $19.85 12/15/20202,580,000 shares $48.63 million -3.4%7.2%13.5 $18.85 11/30/20202,670,000 shares $48.38 million -0.7%7.5%13.8 $18.12 11/15/20202,690,000 shares $52.11 million No Change7.5%14.3 $19.37 10/30/20202,690,000 shares $54.04 million -2.2%7.5%15.1 $20.09 10/15/20202,750,000 shares $57.37 million +2.6%7.7%14.1 $20.86 9/30/20202,680,000 shares $50.25 million +7.2%7.5%12.2 $18.75 9/15/20202,500,000 shares $48.75 million -1.2%7.0%10.6 $19.50 8/31/20202,530,000 shares $51.56 million +0.8%7.1%9.9 $20.38 8/14/20202,510,000 shares $51.05 million -6.3%7.1%8.6 $20.34 7/31/20202,680,000 shares $53.65 million +1.9%7.8%7.8 $20.02 AMPH Short Interest - Frequently Asked Questions What is Amphastar Pharmaceuticals' current short interest? Short interest is the volume of Amphastar Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 4,060,000 shares of AMPH short. 11.74% of Amphastar Pharmaceuticals' shares are currently sold short. Learn More on Amphastar Pharmaceuticals' current short interest. What is a good short interest ratio for Amphastar Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AMPH shares currently have a short interest ratio of 7.0. Learn More on Amphastar Pharmaceuticals's short interest ratio. Which institutional investors are shorting Amphastar Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amphastar Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Amphastar Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.74% of Amphastar Pharmaceuticals' floating shares are currently sold short. Is Amphastar Pharmaceuticals' short interest increasing or decreasing? Amphastar Pharmaceuticals saw a drop in short interest in the month of June. As of June 30th, there was short interest totaling 4,060,000 shares, a drop of 0.5% from the previous total of 4,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Amphastar Pharmaceuticals' float size? Amphastar Pharmaceuticals currently has issued a total of 47,140,000 shares. Some of Amphastar Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Amphastar Pharmaceuticals currently has a public float of 34,580,000 shares. How does Amphastar Pharmaceuticals' short interest compare to its competitors? 11.74% of Amphastar Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Amphastar Pharmaceuticals: ADMA Biologics Inc (7.05%), Vaxcyte, Inc. (11.26%), Rhythm Pharmaceuticals, Inc. (8.12%), Cytokinetics, Incorporated (12.86%), Krystal Biotech, Inc. (12.75%), Akero Therapeutics, Inc. (12.23%), Zai Lab Limited Unsponsored ADR (1.31%), PTC Therapeutics, Inc. (8.01%), Ultragenyx Pharmaceutical Inc. (7.63%), Merus N.V. (7.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Amphastar Pharmaceuticals stock? Short selling AMPH is an investing strategy that aims to generate trading profit from Amphastar Pharmaceuticals as its price is falling. AMPH shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amphastar Pharmaceuticals? A short squeeze for Amphastar Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMPH, which in turn drives the price of the stock up even further. How often is Amphastar Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMPH, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies ADMA Biologics Short Squeeze Vaxcyte Short Squeeze Rhythm Pharmaceuticals Short Squeeze Cytokinetics Short Squeeze Krystal Biotech Short Squeeze Akero Therapeutics Short Squeeze Zai Lab Short Squeeze PTC Therapeutics Short Squeeze Ultragenyx Pharmaceutical Short Squeeze Merus Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMPH) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs this secretive Asian company trying to take over Bitcoin?A mysterious Asian conglomerate is buying billions in Bitcoin — but one legendary trader says that’s the wrong...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amphastar Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amphastar Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
